January 29, 2019

Gamida Cell, Be The Match BioTherapies Team Up on NiCord for Blood Cancers

News

A collaboration between cellular and immune therapeutics firm Gamida Cell and Be The Match BioTherapies is designed to widen the use of bone marrow transplants to treat blood cancers. The partnership ... Read more

October 13, 2016

Potential Alternative to Bone Marrow Transplants Granted FDA Breakthrough Therapy Status

News

NiCord, a novel graft modality developed by Gamida Cell for bone marrow transplants in patients with blood cancers like leukemia and lymphoma, has been granted breakthrough therapy designation by the U.S. Food and ... Read more